Abstract
Repolarization alternans (RA) has been implicated in the pathogenesis of ventricular arrhythmias and sudden cardiac death. We developed a 12-lead, blue-tooth/Smart-Phone (Android) based electrocardiogram (ECG) acquisition and monitoring system (cvrPhone), and an application to estimate RA, in real-time. In in-vivo swine studies (N = 17), 12-lead ECG signals were recorded at baseline and following coronary artery occlusion. RA was estimated using the Fast Fourier Transform (FFT) method using a custom developed algorithm in JAVA. Underlying ischemia was detected using a custom developed ischemic index. RA from each lead showed a significant (p < 0.05) increase within 1 min of occlusion compared to baseline (n = 29). Following myocardial infarction, spontaneous ventricular tachycardia episodes (n = 4) were preceded by significant (p < 0.05) increase of RA prior to the onset of the tachy-arrhythmias. Similarly, the ischemic index exhibited a significant increase following myocardial infarction (p < 0.05) and preceding a tachy-arrhythmic event. In conclusion, RA can be effectively estimated using surface lead electrocardiograms by analyzing beat-to-beat variability in ECG morphology using a smartphone based platform. cvrPhone can be used to detect myocardial ischemia and arrhythmia susceptibility using a user-friendly, clinically acceptable, mobile platform.
Similar content being viewed by others
Introduction
Electrocardiographic (ECG) alternans, a phenomenon of beat-to-beat oscillation in electrocardiographic waveforms during the repolarization phase of the cardiac cycle also known as repolarization alternans (RA), has been demonstrated to be an important marker of cardiac electrical instability and ventricular tachy-arrhythmic events (VTE)1,2. Specifically, the presence of microvolt level RA during low level exercise has been identified as a marker of ventricular arrhythmia susceptibility and can be used to guide implantable cardioverter defibrillator (ICD) therapy in patients with structural heart disease.
However, beyond a risk stratification marker for patients that are candidates to receive ICD therapy, recent clinical studies have also indicated that elevated levels of RA may have important predictive significance of short-term arrhythmia susceptibility. Analysis of body-surface ECG signals from ambulatory patients (Holter monitors) with coronary artery disease has demonstrated a sharp surge in the magnitude of RA within minutes prior to spontaneous VTEs3. Analysis of intra-cardiac electrograms (EGMs) from ICDs has demonstrated a sharp elevation in RA magnitude immediately prior to spontaneous ventricular arrhythmias4,5. However, a similar surge in RA has not been observed prior to induced VTEs or preceding inappropriate ICD discharges5,6. Overall, there is significant evidence to support the notion that a heightened state of RA, measured from intra-cardiac electrodes or body-surface leads, is closely associated with an increased risk to a VTE.
On the other hand, as the average age of the US population increases and chronic conditions are becoming more prevalent, there is a need to improve the effectiveness of disease prevention, to enhance access to healthcare, and to sustain healthy independent living. The increased availability of new technologies and an ever-improving health information technology infrastructure, with >90% of American adults owning a cell phone and 55% having a Smart-Phone7, indicates that mobile-health technologies will soon function not only as monitoring devices of the cardiac and respiratory systems8, but as essential components in managing patients. Therefore, new, low-cost, easy-to-deploy technologies are needed to meet the clinical need for long-term (>1–2 days) respiratory and cardiac monitoring of the ambulatory patient. The central goal of this study is to investigate the hypothesis that one may develop methods for estimating RA, by recording cardiac electrical activity from the body surface, measuring the beat-to-beat variability in the morphology of ECG waveforms, and using the measured beat-to-beat variability to estimate the RA using the on-board computing power of a Smart-Phone, in order to alert the patient and the treating physician of an impending arrhythmia.
Methods
Animal studies
17 male Yorkshire swine (40–45 kg) were anesthetized and instrumented in the Animal Electrophysiology Laboratory of the Massachusetts General Hospital, following previously described methods9. Anesthesia was maintained with Isoflurane (1.5–5%), and each animal was intubated and was mechanically ventilated. Ιnvasive blood pressure was monitored through an arterial line.
Briefly, percutaneous vascular access was obtained in the jugular veins and femoral arteries and veins, as previously described, using standard Seldinger techniques10. Decapolar catheters were placed in the coronary sinus (CS), right ventricle (RV), right atrium (RA), and left ventricle (LV). An inferior vena cava catheter was inserted as a reference electrode for unipolar signals.
Percutaneous techniques were used to induce coronary artery ischemia, in a closed-chest model9,11,12,13,14. Briefly, either the mid left circumflex or the mid left anterior descending coronary arteries were occluded with a balloon using standard angioplasty techniques. Ischemia was validated and confirmed by hand injections of contrast into the coronary in which case no-flow, or manifestation of ECG changes were indications of full occlusion. Intravenous unfractionated heparin was administered (4000 units prior to engaging the coronary artery, followed by 1000 units/hour during balloon inflation).
The hardware architecture
The hardware architecture of the system has been previously described8. Briefly, the ECG device is composed of an analog-to-digital (A/D) converter, a microcontroller board, and a Bluetooth module (Fig. 1A). Following amplification and digitization of the analog ECG signal by the AD converter, they are transmitted by the microcontroller to the smartphone at the user’s request (Fig. 1B). We have validated that signals can be uninterruptedly communicated through the Bluetooth, up to 10 m away from the smartphone, at a baud rate of 115200. The microcontroller was programmed using the open-source, Arduino 1.5.4.
The settings of the AD converter were: sampling rate at 500 samples/s, gain at 12 and reference voltage at 24 V. Reference voltage for the precordial leads was the Wilson Central Terminal defined as RA + LA + LL)/3). Although, the AD converter has 24 bit resolution, that was reduced to 16 bit in order to reduce the transmission load via Bluetooth. The range of the ECG signal is ±12.5 mV, and its resolution is ~0.38 μV.
Android smartphone application
The application is consisted of three threads: the user-interface, the Bluetooth, and the real-time-calculation. The user is provided with diverse options through the user-interface thread, such as to display the ECG signals and the estimation results. The Bluetooth thread receives the ECG signals from the microcontroller. The real-time-calculation thread estimates RA indices for each lead, independently, and in real-time.
Body surface ecg data analysis
RA is estimated using a previously described algorithm2,4,9,15. Briefly, we first obtain preliminary R-wave detection by applying a software-based QRS detection algorithm to a selected ECG lead. These, preliminary R-wave detections are refined and abnormal beats (i.e. premature ventricular complexes -PVCs- and aberrantly conducted beats) are identified by employing a template-matching QRS alignment algorithm and substituted with a median odd or even template beat (estimated from the odd or even ‘normal’ beats respectively in the 128 beat sequence), depending on whether the abnormal beat is an odd or an even beat2,9
Then, repolarization interval boundaries for RA analysis are independently determined for each of the body surface leads, due to variability in the morphology and timing of the T-wave between leads. Briefly, the power method identifies the onset/offset points at time points corresponding to 5% and 95% of the cumulative sum of the signal power16, is used for ECG signal waveform annotation.
The, RA is estimated using the spectral method for each 128-beat data sequence (using a 512-point power spectrum to improve the frequency-domain resolution), as previously described2,9,15,17. For each lead, spectral analysis is independently performed in order to account for the spatial variability of RA, and RA indices are estimated as follows:
where, the alternans peak is the peak in the aggregate power spectrum corresponding to 0.5 cycles/beat and the mean (µnoise) and the standard deviation (σnoise) of the alternans noise are estimated in a predefined spectral window (0.43–0.46 cycles/beat) of the power spectrum. The alternans voltage measures directly the presence of RA while the Kscore is a measure of the statistical significance of the alternans voltage. For each lead, RA is estimated on a beat-by-beat basis using a rolling 128-beat window that is shifted one beat at a time.
Ischemic index estimation
ST-segment elevation or depression has been well established as a significant marker of MI18. We have previously introduced the ischemic index19, which is defined as the absolute value of the ratio of ST-height to the QR-amplitude. The ST-height is defined as the mean amplitude of the whole ST-segment above or below the isoelectric baseline, when the polarity at both ends of the ST-segment is the same; if the polarity is different, then the longer segment is selected as the ST-height.
Assessment of arrhythmia susceptibility
Arrhythmia susceptibility, under varying states of RA, was assessed using programmed ventricular stimulation (PVS)20, in which a positive outcome was defined as sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) lasting >30 secs or requiring external defibrillation.
Pacing pulses during PVS were delivered from LV15 and had amplitude and duration 50 mA and 2 msec, respectively. PVS was initiated with a drive train of 8 beats (S1) at a cycle length of 400 milliseconds (ms) with an extra-stimulus (S2) delivered at a coupling interval of approximately 300 ms. The coupling interval for S2 was reduced in 10 ms steps until ventricular refractoriness was reached, at which point S2 was fixed at 20 ms above the point of refractoriness and an S3 was added beginning at a coupling interval 10 ms less than S2. This process was repeated until sustained VT/VF was induced or ventricular refractoriness was reached on S6, in which case PVS was deemed non-inducible under those conditions.
In order to quantify the outcomes of PVS across different RA states, we developed a single “score” rank parameter (Srank) which assigned the highest score (highest arrhythmia susceptibility) to the intervention that required (i) the smallest number of extra-stimuli during PVS to induce an arrhythmia, or (ii) if the number of extra-stimuli was the same, to the intervention with the smallest coupling interval between S1 and Slast, both of which suggest less aggressive stimulation was necessary to induce sustained VT/VF reflecting a more vulnerable arrhythmic substrate. We recognize that there is no single best validated clinical method to assess arrhythmia susceptibility in a fully quantifiable manner. The Srank score was developed not as surrogate of VT/VF (with a binary outcome), but rather as a method to obtain a quantitative relationship between the level of RA and the likelihood of inducing VT/VF.
If sustained VT/VF was induced, biphasic external defibrillation was performed using 150 joules with paddles placed on the chest of the animal and a rest period of ~10 min was allowed after each positive PVS.
Statistical methods
Aggregate variables are expressed as mean ± standard deviation. Box-plot representation including the median, 90–10% and 75–25% percentiles was used to demonstrate statistical properties of the estimated data sequences. For each RA parameter, a baseline distribution was obtained by collecting the values of that parameter over all time periods before occlusion (t < = 0). Comparisons were then made for each of the alternans noise (µnoise), alternans voltage and Kscore, for each lead, between the baseline distribution and the distribution corresponding to each minute after occlusion (t > 0), and a p value was obtained using the Kruskal Wallis test. A threshold value of 0.05 divided by the number of time intervals after occlusion was calculated. Statistical significance at any time interval was then determined based on two factors: (i) the p value resulting from the comparison between the baseline distribution with distribution at that particular interval is less than the threshold value, and (ii) the median of the baseline distribution is less than the median of the distribution at that particular interval. A statistically significant p value is denotted by an “*. Statistical analysis was performed using MATLAB (MathWorks Inc, Natick, MA).
Ethical approval
The animal studies were approved by the institutional review board and the subcommittee on research animal care at Massachusetts General Hospital. All experiments were performed in accordance with relevant guidelines and regulations.
Results
Smartphone-based repolarization alternans estimation
In Fig. 2, we observe summary results (n = 29 records, N = 17 animals) of coronary artery occlusion induced temporal changes of the estimated RA (that involves both the ST-segment and T-wave) indices: (A) alternans noise (µnoise), (B) alternans voltage, and (C) Kscore. Time zero indicates the timing of the balloon inflation. Across all 12 ECG leads a significant change (p < 0.05) of the alternans noise (in a few leads), voltage and Kscore after occlusion, compared to before occlusion, is observed.
Repolarization alternans before a tachy-arrhythmic event
In Fig. 3, we present a sample ECG signal (lead V3) during coronary artery occlusion, while the heart-rhythm transitions from sinus to VT. In Fig. 4A–C, we observe summary results of the alternans indices following myocardial infarction, reflecting temporal changes that led led to spontaneous VT/VF (n = 4 records; N = 4 animals): (A) alternans noise (µnoise), (B) alternans voltage, and (C) Kscore. Time zero indicates the timing of the balloon inflation. We observe that the alternans noise level was statistically different (p < 0.05) before compared to after occlusion, and also ischemia led to a statistically significant increase of the alternans voltage (p < 0.05) and Kscore (p < 0.05) after occlusion, compared to before occlusion.
We compared distributions of alternans noise (µnoise), alternans voltage, and Kscore, between records that exhibited VT/VF (n = 4) and those that did not (n = 25), following myocardial infarction (at times: 0, 1, 2, 3 and 4 min), and we report the obtained range of p-values, resulting from this comparison, in Table 1.
To examine the sensitivity of the 12 lead system in detecting RA we calculated the conditional probability that any one lead in a combination of N leads is positive, given that at least one lead out of all 12 leads is positive: P(any one in N leads is positive | one of 12 leads is positive). We define as positive RA an estimate that satisfies the following criteria: (i) alternans voltage is higher than 0.55 μV, and (ii) Kscore is higher than 39. If at any instance, we find that any one of the 12 leads is positive, we evaluate if positive alternans can be detected with a combination of N leads, with N ranging from one to twelve. All combinations of N leads out of 12 have been considered for this purpose. Then, the probability for a specific combination of leads is calculated by the ratio between the number of times a positive detection was made to the total number of positive detections by the 12 leads. Once the probabilities are computed over all combinations of size N across all 29 recordings, the average probability over the 29 recordings for each combination was calculated, and the combination yielding the maximum probability for a specific number of leads was reported (Fig. 5). We observe that four leads provide higher than 80% probability that RA is detected and that number raised to more than 90% with six leads.
Repolarization alternans burden
In Fig. 6, we present the alternans burden (%) before and after coronary artery occlusion during MI (n = 29 records; N = 17 animals). Again, we define as positive an RA an estimate that satisfies the criteria above for (i) alternans voltage is higher than 0.55 μV, and (ii) Kscore is higher than 39.
The incidence of RA is evaluated on a beat-by-beat basis, and the RA burden is evaluated as a percent of sequences that exhibit significant RA; the RA burden is estimated separately after the occlusion, for each record.
We observe that during MI the RA burden is significantly higher (p < 0.05, using the paired T-test), compared to baseline.
Relationship of ischemic index and repolarization alternans
Next, we sought to explore the relationship of RA vs the ischemic index during MI (Fig. 7A) and preceding VT/VF (Fig. 7B). In each figure, the alternans voltage (μV) versus ischemic index is presented in the upper panel, and the Kscore versus ischemic index, is presented in the lower panel. The color bars on the right side indicate the time after coronary artery occlusion from 0 min to 5 min. The dashed line in each plot represents a data fitting line with a single-term exponential model.
In Fig. 7C, we observe that for both the alternans voltage (p < 0.05) and Kscore (p < 0.05, using the paired t-test) the constant of the exponential model is significantly smaller before VT/VF, indicating that RA manifests a profound arrhythmogenic substrate.
RA and arrhythmia susceptibility
To assess the arrhythmogenic potential of RA we employed PVS that was performed at baseline and after coronary artery occlusion (N = 9).
We observed that the Srank at baseline and after coronary artery occlusion was not statistically different (Fig. 7D), yet it trended towards a higher value after occlusion associating RA with a higher arrhythmogenic risk.
Discussion
In this study, we have shown that RA can be effectively estimated from body surface ECG signals, through Bluetooth, using a smartphone; second, the smartphone can provide a viable platform to process ECG signals in real-time and, if needed, enable generation of alerts for the patient and the treating physician of an impending arrhythmia while the patient maintains an ambulatory status; third, there is a strong connection between RA and the ischemic index, especially before a tachy-arrhythmic event, indicating the significance of RA in predicting a tachy-arrhythmic event, at least in this model.
Optical mapping studies in normal hearts have shown that discordant (reflecting two areas in the heart that oscillate with opposing phase) APD alternans is linked to a state of reduced cardiac electrical stability, manifested by the observation that when alternans is followed by VF, it only occurs after discordant APD alternans, but never concordant APD alternans21.
RA estimated in Holter ECG signals in ambulatory patients with coronary artery disease has shown a marked surge in RA magnitude within minutes preceding a spontaneous VTE3. T-wave alternans (TWA) amplitude reached a peak about 10 min prior to the onset of a VTE. Sharp surges in TWA immediately preceding spontaneous VTEs have also been documented in body-surface ECGs in patients hospitalized for acute heart failure22; TWA increased from a baseline during 15–30 mins prior to the onset of the VTE and remained elevated until the occurrence of VTE. RA estimated in intra-cardiac EGMs from ICDs has shown a sharp surge prior to spontaneous VTEs4,5; however, a similar RA surge has not been noticed prior to induced VTEs or prior to inappropriate ICD shocks5. Recently a prospective study in patients with ICDs has confirmed these findings6; specifically, the magnitude of T-wave alternans/variability (TWA/V) prior to spontaneous VTE was significantly higher than during any of the control segments, while logistic regression analysis has shown that each 10 μV increase in TWA/V was associated with a 2.2 odds increase of developing a VTE. These observations establish a close temporal relationship between surges in TWA/V and the onset of spontaneous VTEs.
On the other hand, the ischemic index, that quantifies beat-to-beat changes observed in both ventricular depolarization and repolarization during ischemia, provides a personalized, lead-independent measure that accounts for both depolarization23,24 and repolarization25,26,27 changes observed during MI. In this study, as well as in prior studies28, we have seen that despite the dynamic beat-to-beat and subject-to-subject variability of ECG morphology, the ischemic index presents high stability as well as very low intra- and inter-subject variability under baseline (non-ischemic) conditions28, while it exhibits great spatial sensitivity in detecting MI-induced changes and has been linked to VTEs28.
In summary, although the magnitude of RA increases in body-surface leads is smaller than that measured in intra-cardiac EGMs9, simultaneous measurement of RA from body-surface and intra-cardiac EGMs by our group9 and others29 has shown a high degree of correlation suggesting that these measurements are reflecting the same electrical phenomenon. The data presented in this study as well as by others support the idea that a sharp increase of RA prior to the onset of spontaneous VTE can be measured from body-surface electrodes and may be used to predict acute arrhythmia susceptibility. In such scenario, a heightened state of the ischemic index and/or RA (compared to that subject’s baseline levels, personalized health care) could serve as a warning and indication that the subject should adopt behavioral changes (i.e. stop exercising) or take medication (i.e. a b-blocker), or seek medical attention.
Data Availability
The data will be available to any investigator upon request.
References
Ritzenberg, A. L., Adam, D. R. & Cohen, R. J. Period multupling-evidence for nonlinear behaviour of the canine heart. Nature 307, 159–161 (1984).
Smith, J. M., Clancy, E. A., Valeri, C. R., Ruskin, J. N. & Cohen, R. J. Electrical alternans and cardiac electrical instability. Circulation 77, 110–121 (1988).
Shusterman, V., Goldberg, A. & London, B. Upsurge in T-wave alternans and nonalternating repolarization instability precedes spontaneous initiation of ventricular tachyarrhythmias in humans. Circulation 113, 2880–2887 (2006).
Armoundas, A. A., Albert, C. M., Cohen, R. J. & Mela, T. Utility of implantable cardioverter defibrillator electrograms to estimate repolarization alternans preceding a tachyarrhythmic event. J Cardiovasc Electrophysiol 15, 594–597, https://doi.org/10.1046/j.1540-8167.2004.03411.x (2004).
Kim, J. W. et al. Defibrillator electrogram T wave alternans as a predictor of spontaneous ventricular tachyarrhythmias in defibrillator recipients. Circ J 73, 55–62 (2009).
Swerdlow, C. et al. Intracardiac electrogram T-wave alternans/variability increases before spontaneous ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients: a prospective, multi-center study. Circulation 123, 1052–1060 (2011).
Pew Research Internet Project. Mobile technology fact sheet, http://www.pewinternet.org/fact-sheets/mobile-technology-fact-sheet (2014).
Sohn, K. et al. A Novel Point-of-Care Smartphone Based System for Monitoring the Cardiac and Respiratory Systems. Scientific reports 7, 44946, https://doi.org/10.1038/srep44946 (2017).
Weiss, E. H. et al. A novel lead configuration for optimal spatio-temporal detection of intracardiac repolarization alternans. Circ Arrhythm Electrophysiol 4, 407–417 (2011).
Wilber, D., Garan, H. & Ruskin, J. Electrophysiologic testing in survivors of cardiac arrest. Circulation 75, 146–153 (1987).
Merchant, F. M., Sayadi, O., Moazzami, K., Puppala, D. & Armoundas, A. A. T-wave alternans as an arrhythmic risk stratifier: state of the art. Curr Cardiol Rep 15, 398 (2013).
Merchant, F. M. et al. A translational approach to probe the proarrhythmic potential of cardiac alternans: a reversible overture to arrhythmogenesis? Am J Physiol Heart Circ Physiol 306, H465–474 (2014).
Saul, J. P., Rea, R. F., Eckberg, D. L., Berger, R. D. & Cohen, R. J. Heart rate and muscle sympathetic nerve variability during reflex changes of autonomic activity. Am J Physiol 258, H713–721 (1990).
Sayadi, O. et al. A novel method for determining the phase of T-wave alternans: diagnostic and therapeutic implications. Circ Arrhythm Electrophysiol 6, 818–826 (2013).
Rosenbaum, D. S. et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330, 235–241 (1994).
Merri, M. et al. In Proceedings. Computers in Cardiology 85–87 (1988).
Armoundas, A. A., Albert, C. M., Cohen, R. J., Mela, T. & Investigators, T. Utility of implantable cardioverter defibrillator electrograms to estimate repolarization alternans preceding a tachyarrhythmic event. Journal of cardiovascular electrophysiology 15, 594–597, https://doi.org/10.1046/j.1540-8167.2004.03411.x (2004).
Myerburg, R. J., Kessler, K. M. & Castellanos, A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 85, I2–10 (1992).
Zhang, L., Hou, Y. & Po, S. S. Obstructive Sleep Apnoea and Atrial Fibrillation. Arrhythm Electrophysiol Rev 4, 14–18 (2015).
Donahue, J. K. et al. Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med 6, 1395–1398 (2000).
Laurita, K. R., Pastore, J. M. & Rosenbaum, D. S. In Cardiac Electrophysiology: From Cell to Bedside (eds Zipes, D. P. & Jalife, J.) 239–248 (W.B.Saunders, 1999).
Nearing, B. D. et al. Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure. Circ Arrhythm Electrophysiol 5, 84–90, https://doi.org/10.1161/CIRCEP.111.965434 (2012).
Ringborn, M. et al. Comparison of high-frequency QRS components and ST-segment elevation to detect and quantify acute myocardial ischemia. J Electrocardiol 43, 113–120 (2010).
Romero, D., Ringborn, M., Laguna, P., Pahlm, O. & Pueyo, E. Depolarization changes during acute myocardial ischemia by evaluation of QRS slopes: standard lead and vectorial approach. IEEE Trans Biomed Eng 58, 110–120 (2011).
Holland, R. P. & Brooks, H. TQ-ST segment mapping: critical review and analysis of current concepts. Am J Cardiol 40, 110–129 (1977).
Krucoff, M. W. et al. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol 71, 145–151 (1993).
Shah, A. et al. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the “gold standard” for myocardial reperfusion assessment. J Am Coll Cardiol 35, 666–672 (2000).
Sayadi, O. et al. A novel method to capture the onset of dynamic electrocardiographic ischemic changes and its implications to arrhythmia susceptibility. J Am Heart Assoc 3 (2014).
Paz, O. et al. Detection of T-wave alternans using an implantable cardioverter-defibrillator. Heart Rhythm 3, 791–797 (2006).
Acknowledgements
The work was supported by a Grand-in-Aid (#15GRNT23070001) from the American Heart Association (AHA), the RICBAC Foundation, NIH grant 1 R01 HL135335-01, 1 R21 HL137870-01 and 1 R21EB026164-01 and a Founders Affiliate Post-doctoral Fellowship (#15POST22690003) from the AHA. This work was conducted with support from Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8UL1TR000170-05 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health.
Author information
Authors and Affiliations
Contributions
Kwanghyun Sohn, PhD: Participated in the development of the algorithms, the animal studies, the data analysis, writing the manuscript. Steven P. Dalvin, MD: Participated in the development of the algorithms, the data analysis, writing the manuscript. Faisal M. Merchant, MD: Participated in the conception of the study, the animal studies, writing the manuscript. Kanchan Kulkarni, PhD: Participated in the animal studies, writing the manuscript. Furrukh Sana, PhD: Participated in the data analysis, writing the manuscript. Shady Abohashem, MD: Participated in the animal studies, writing the manuscript. Jagmeet P. Singh, MD, PhD: Participated in the conception of the study, writing the manuscript. E. Kevin Heist, MD, PhD: Participated in the conception of the study, writing the manuscript. Chris Owen, MS: Participated in the animal studies. Eric M. Isselbacher, MD, MSc: Participated in the conception of the study, writing the manuscript. Antonis A. Armoundas, PhD: Participated in the conception of the study, the animal studies, the development of the algorithms, data analysis, writing the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sohn, K., Dalvin, S.P., Merchant, F.M. et al. Utility of a Smartphone Based System (cvrPhone) to Predict Short-term Arrhythmia Susceptibility. Sci Rep 9, 14497 (2019). https://doi.org/10.1038/s41598-019-50487-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-50487-4
- Springer Nature Limited